2CBCB-NBOMe (NBOMe-TCB-2) is a compound indirectly derived from the
phenethylamine
Phenethylamine (PEA) is an organic compound, natural monoamine alkaloid, and trace amine, which acts as a central nervous system stimulant in humans. In the brain, phenethylamine regulates monoamine neurotransmission by binding to trace amin ...
series of
hallucinogen
Hallucinogens are a large, diverse class of psychoactive drugs that can produce altered states of consciousness characterized by major alterations in thought, mood, and perception as well as other changes. Most hallucinogens can be categorized ...
s, which was discovered in 2007 at
Purdue University
Purdue University is a public land-grant research university in West Lafayette, Indiana, and the flagship campus of the Purdue University system. The university was founded in 1869 after Lafayette businessman John Purdue donated land and money ...
as part of the ongoing research program of the team led by
David Nichols focusing on the mapping of the specific amino acid residues responsible for ligand binding to the
5HT2A receptor
Receptor may refer to:
* Sensory receptor, in physiology, any structure which, on receiving environmental stimuli, produces an informative nerve impulse
*Receptor (biochemistry), in biochemistry, a protein molecule that receives and responds to a ...
. 2CBCB-NBOMe acts as a potent and selective
agonist
An agonist is a chemical that activates a receptor to produce a biological response. Receptors are cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an antagonist blocks the action of the ago ...
for the 5-HT
2A and 5-HT
2C receptors, with a
Ki of 0.27 nM at the human 5-HT
2A receptor, a similar potency to other agonists such as
TCB-2
TCB-2 is a hallucinogen discovered in 2006 by Thomas McLean working in the lab of David Nichols at Purdue University. It is a conformationally-restricted derivative of the phenethylamine 2C-B, also a hallucinogen, and acts as a potent agonist ...
,
NBOMe-2C-I and
Bromo-DragonFLY.
Analogues and derivatives
Legality
United Kingdom
United States
2CBCB-NBOMe is a controlled substance in Vermont as of January 2016.
References
5-HT2A agonists
5-HT2C agonists
25-NB (psychedelics)
Benzocyclobutenes
Bromoarenes
Designer drugs
Psychedelic drugs
{{hallucinogen-stub